CVS Health Corp. closed 16.78% short of its 52-week high of $80.75, which the company reached on March 28th.

Shares of CVS Health Corp. CVS slipped 1.61% to $66.48 Tuesday, on what proved to be an all-around positive trading session ...

The Washington Spirit say their partnership renewal with CVS Health is a "multimillion-dollar investment" among the most ...

CVS Health's CVS short percent of float has fallen 12.83% since its last report. The company recently reported that it has 20 ...

The NWSL Washington Spirit and CVS Health will announce a three-year partnership renewal that is “among the most valuable ...

CVS Health (CVS) closed the most recent trading day at $67.20, moving +1.08% from the previous trading session. This move outpaced the S&P 500's daily loss of 1.12%. Meanwhile, the Dow lost 0.31%, and ...

We recently published a list of 13 Best Healthcare Dividend Stocks to Invest in. In this article, we are going to take a look ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on CVS Health (CVS – Research Report) and Verastem ...

CVS Health is reevaluating its role in healthcare as financial pressures mount. The company, along with other major retailers ...

CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Wells Fargo analyst Stephen Baxter maintained a Buy rating on CVS Health (CVS – Research Report) on March 14 and set a price target of $73.00.